Nicotine dependence linked to symptom severity in schizophrenia

NewsGuard 100/100 Score

By Mark Cowen, Senior medwireNews Reporter

Nicotine dependence is associated with increased symptom severity in patients with schizophrenia, UK study results show.

The team found that schizophrenia patients with severe nicotine dependence had greater positive symptom severity than nonsmokers, while those with mild-moderate dependence had greater negative symptom severity than nonsmokers.

In turn, greater symptom severity was associated with poorer social adjustment, indicating an indirect link between nicotine dependence and social adjustment, say the authors.

"Although our study does not establish a causal relationship between these variables [nicotine dependence and symptom severity], identifying and treating nicotine dependence may have some value in reducing morbidity and mortality in schizophrenia," they write in the British Journal of Psychiatry.

The researchers studied 131 people diagnosed with schizophrenia who were living in Nithsdale, Scotland, in 2006.

All of the participants were assessed using the Fagerström Test for Nicotine Dependence (FTND), with severe dependence defined as a score greater than 6 and mild-moderate dependence as a score of 6 or less.

In total, 70 (53.4%) patients were current smokers at the time of assessment and 61 were nonsmokers, of whom 21 were exsmokers. Of the smokers, 50 (71%) fulfilled criteria for severe dependence and 20 (29%) for mild-moderate dependence.

Participants with severe nicotine dependence had significantly higher mean scores on the positive subscale of the Positive and Negative Syndrome Scale (PANSS) than nonsmokers, at 12.46 versus 10.38. And patients with mild-moderate nicotine dependence had significantly higher negative subscale scores on the PANSS than nonsmokers, at 16.56 versus 13.32.

The difference in negative subscale PANSS scores between those with severe nicotine dependence and nonsmokers was not significant, nor was the difference in positive subscale scores between patients with mild-moderate nicotine dependence and nonsmokers.

There was a significant association between overall scores on the Social Adjustment Scale Self Report (SAS-SR) and PANSS positive, negative, and general psychopathology subscale scores. Although there was no direct association between SAS-SR scores and smoking dependency, there was an indirect effect, where greater PANSS positive symptom scores mediated the relationship between greater nicotine dependence and worse overall SAS-SR scores.

In the nonsmokers, there was no significant difference between exsmokers and never-smokers regarding PANSS positive and negative subscale scores and SAS-SR scores.

Rajeev Krishnadas (University of Glasgow) and team conclude: "Nicotine dependence was found to be associated with symptom severity and outcome in people with schizophrenia."

They add: "Further systematic longitudinal studies are required to establish whether a causal link exists between nicotine dependence and psychopathology."

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

  1. Jim Jim United States says:

    The article implies a link but is it in fact that someone with the condition is more likely to be a heavy smoker or the inverse. The stats simply demonstrate a relationship not the direct relation or cause and effect.  My son has the condition and advises that he debends on the smokes to calm himself down. He would not agree that the smoking influences his symptoms in the negative way, he sees it as a positive way.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Vanderbilt's potential schizophrenia treatment enters phase 1 clinical trials